{"id":"epinephrin-0-07","safety":{"commonSideEffects":[{"rate":null,"effect":"Tachycardia"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Tremor"},{"rate":null,"effect":"Anxiety"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Arrhythmias"},{"rate":null,"effect":"Myocardial ischemia"}]},"_chembl":{"chemblId":"CHEMBL1951853","moleculeType":"Small molecule","molecularWeight":"267.28"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Epinephrine binds to alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors on target tissues. This activation increases cardiac contractility and heart rate (beta-1), causes vasoconstriction (alpha-1), and promotes bronchial smooth muscle relaxation (beta-2). The 0.07 concentration indicates a dilute formulation typically used for local or systemic administration.","oneSentence":"Epinephrine is a catecholamine that activates alpha and beta adrenergic receptors to increase heart rate, blood pressure, and bronchial dilation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:39:14.159Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Anaphylaxis"},{"name":"Cardiac arrest"},{"name":"Severe hypotension"},{"name":"Acute bronchospasm"},{"name":"Local hemostasis and vasoconstriction in surgical procedures"}]},"trialDetails":[{"nctId":"NCT07169240","phase":"PHASE1","title":"Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BT-114143 Injection in Healthy Subjects","status":"COMPLETED","sponsor":"ScinnoHub Pharmaceutical Co., Ltd.","startDate":"2023-02-06","conditions":"Healthy Subjects (HS)","enrollment":84},{"nctId":"NCT05051150","phase":"PHASE4","title":"Epinephrine Infusion for Prophylaxis Against Maternal Hypotension During Caesarean Section","status":"TERMINATED","sponsor":"Kasr El Aini Hospital","startDate":"2021-09-15","conditions":"Post-spinal Hypotension, Cesarean Section","enrollment":18}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Epinephrin 0.07","genericName":"Epinephrin 0.07","companyName":"Kasr El Aini Hospital","companyId":"kasr-el-aini-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Epinephrine is a catecholamine that activates alpha and beta adrenergic receptors to increase heart rate, blood pressure, and bronchial dilation. Used for Anaphylaxis, Cardiac arrest, Severe hypotension.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}